SEC Form 4 · accession 0001415889-17-000471
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Wayne Schoenbart
Officer — CEO, CFO AND SECRETARY · Director
Period of report
Nov 25, 2016
Accepted (ET)
Mar 22, 2017 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.01F1 | Nov 25, 2016 | F | 28,000 | $0.34 | D | 74,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by Issuer to pay tax on vested stock granted under the 2008 Equity Incentive Plan.